Literature DB >> 11831785

Drug discrimination under concurrent variable-ratio variable-ratio schedules.

D E McMillan1, W C Hardwick, Mi Li.   

Abstract

Pigeons were trained to discriminate 5 mg/kg pentobarbital from saline under concurrent variable-ratio (VR) VR schedules, in which responses on the pentobarbital-biased lever were reinforced under the VR schedule with the smaller response requirements when pentobarbital was given before the session, and responses on the saline-biased key were reinforced under the VR schedule with the larger response requirements. When saline was administered before the session, the reinforcement contingencies associated with the two response keys were reversed. When responding stabilized under concurrent VR 20 VR 30, concurrent VR 10 VR 40, or concurrent VR 5 VR 50 schedules, pigeons responded almost exclusively on the key on which fewer responses were required to produce the reinforcer. When other doses of pentobarbital and other drugs were substituted for the training dose, low doses of all drugs produced responding on the saline-biased key. Higher doses of pentobarbital and chlordiazepoxide produced responding only on the pentobarbital-biased key, whereas higher doses of ethanol and phencyclidine produced responding only on this key less often. d-Amphetamine produced responding primarily on the saline-biased key. When drugs generalized to pentobarbital, the shape of the generalization curve under concurrent VR VR schedules was more often graded than quantal in shape. Thus, drug discrimination can be established under concurrent VR VR schedules, but the shapes of drug-discrimination dose-response curves under concurrent VR VR schedules more closely resemble those seen under interval schedules than those seen under fixed-ratio schedules. Graded dose-response curves under concurrent VR VR schedules may relate to probability matching and difficulty in discriminating differences in reinforcement frequency.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11831785      PMCID: PMC1284849          DOI: 10.1901/jeab.2002.77-91

Source DB:  PubMed          Journal:  J Exp Anal Behav        ISSN: 0022-5002            Impact factor:   2.468


  27 in total

1.  Drug discrimination under a concurrent fixed-ratio fixed-ratio schedule.

Authors:  D E McMillan; M Li
Journal:  J Exp Anal Behav       Date:  1999-09       Impact factor: 2.468

2.  Effects of training history on drug discrimination under concurrent fixed-interval schedules.

Authors:  D E McMillan; M Li
Journal:  Behav Pharmacol       Date:  1999-07       Impact factor: 2.293

3.  Discriminative effects of combinations of delta 9-tetrahydrocannabinol and pentobarbital in pigeons.

Authors:  T U Järbe; G C Ohlin
Journal:  Psychopharmacology (Berl)       Date:  1979-06-21       Impact factor: 4.530

4.  Maximizing and matching on concurrent ratio schedules.

Authors:  R J Herrnstein; D H Loveland
Journal:  J Exp Anal Behav       Date:  1975-07       Impact factor: 2.468

5.  Concurrent variable-ratio schedules: Implications for the generalized matching law.

Authors:  J S Macdonall
Journal:  J Exp Anal Behav       Date:  1988-07       Impact factor: 2.468

6.  Drug discrimination under a concurrent fixed-interval fixed-interval schedule.

Authors:  D E McMillan; M Li; W C Hardwick
Journal:  J Exp Anal Behav       Date:  1997-09       Impact factor: 2.468

7.  Discriminative stimulus properties of d-amphetamine-pentobarbital combinations.

Authors:  J M Witkin; R B Carter; L A Dykstra
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

8.  Matching, undermatching, and overmatching in studies of choice.

Authors:  W M Baum
Journal:  J Exp Anal Behav       Date:  1979-09       Impact factor: 2.468

9.  Drug discrimination under two concurrent fixed-interval fixed-interval schedules.

Authors:  D E McMillan; M Li
Journal:  J Exp Anal Behav       Date:  2000-07       Impact factor: 2.468

10.  Drug discrimination under a concurrent schedule.

Authors:  S H Snodgrass; D E McMillan
Journal:  J Exp Anal Behav       Date:  1996-05       Impact factor: 2.468

View more
  1 in total

1.  Drug Discrimination and the Analysis of Private Events.

Authors:  Brian D Kangas; David R Maguire
Journal:  Behav Anal (Wash D C)       Date:  2016-03-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.